{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-23-000073","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2023-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.568521+00:00","generated_at":"2026-06-09T04:52:35.424482+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nautilus Biotechnology Q3 net loss $15.9M, op ex up 21% YoY to $19.1M","bullets":["Net loss of $15.9M for Q3 2023 vs. $14.1M in Q3 2022.","Operating expenses rose 21% YoY to $19.1M, driven by increased headcount for product development.","Cash, cash equivalents and investments totaled $275.7M as of Sept. 30, 2023.","Company reiterates focus on commercial platform launch in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-23-000073","json":"https://secwatch.observer/filing/0001808805-23-000073.json","markdown":"https://secwatch.observer/filing/0001808805-23-000073.md","text":"https://secwatch.observer/filing/0001808805-23-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000073/0001808805-23-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000073/naut-20231031.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T04:52:35.424482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ffd5da84005e939b33394c54baaa6311d84dcbe0","claim":"Nautilus Biotechnology, Inc. reported the third quarter ended September 30, 2023 results: net income $15.9 million.","evidence_excerpt":"Net loss was $15.9 million for the third quarter of 2023, as compared to a net loss of $14.1 million for the corresponding prior year period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808805/000180880523000073/0001808805-23-000073-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Net income","value":"$15.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}